Jane Street’s BioVie BIVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69.6K Buy
35,860
+13,069
+57% +$20.5K ﹤0.01% 10792
2026
Q1
$31.9K Buy
22,791
+12,316
+118% +$15.8K ﹤0.01% 11097
2025
Q4
$12.2K Buy
+10,475
New +$16.9K ﹤0.01% 10808
2025
Q3
Sell
-6,174
Closed -$57.1K 10793
2025
Q2
$57.1K Buy
+6,174
New +$61K ﹤0.01% 9146
2024
Q3
Sell
-1,762
Closed -$70.6K 9585
2024
Q2
$70.6K Buy
+1,762
New +$84.3K ﹤0.01% 8844
2023
Q2
Sell
-258
Closed -$208K 8675
2023
Q1
$208K Buy
+258
New +$171K ﹤0.01% 7787

Other funds holding BIVI

Jane Street's BIVI Position: Q2 2026 in Review

Jane Street increased its BioVie (BIVI) stake by 57% in Q2 2026, buying an estimated $20.5K and bringing the position to 35,860 shares worth $69.6K. The position accounts for ﹤0.01% of the portfolio, ranked #10792.

Jane Street first reported a position in BIVI in Q1 2023 and has held it in 6 quarters since. The position peaked at $208K in Q1 2023. 36 funds tracked by Wall St. Rank hold BIVI as of Q2 2026.

  • Jane Street held 35,860 shares of BioVie worth $69.6K as of Q2 2026.
  • Jane Street bought 13,069 BioVie shares in Q2 2026, an estimated $20.5K.
  • BioVie made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10792 holding.
  • Jane Street first reported a position in BioVie in Q1 2023 and has held it in 6 quarters since.
  • Jane Street's BioVie position peaked at $208K in Q1 2023.
  • 36 funds tracked by Wall St. Rank held BioVie as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.